MICHAEL HANGER: Open Payments
NPI 1215484753 · WEST POINT, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 36 payments from 11 companies in 2025. Trend: 2023 $1,389 · 2024 $1,465 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $208 |
| PFIZER INC. | 7 | $133 |
| ABBVIE INC. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Edwards Lifesciences Corporation | 1 | $18 |
Products named: Auvelity, PREVNAR 20, CAPLYTA, AIRSUPRA, UBRELVY, NURTEC ODT, AREXVY, QULIPTA.
Industry payments across VA — which companies pay providers there.
